Applied Genetic Technologies reported $85.81M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Applied Genetic Technologies AGTC:US $ 85.81M 11.19M
Avrobio Inc AVRO:US $ 220.99M 11.94M
Biogen BIIB:US $ 10429.9M 322M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Celldex Therapeutics CLDX:US $ 182.28M 11.88M
Cti Biopharma CTIC:US $ 61.71M 35.05M
Gilead Sciences GILD:US $ 19710M 758M
Insmed INSM:US $ 531.05M 329.42M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
Life Technologies LIFE:US $ 40.98M 8.73M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Rigel Pharmaceuticals RIGL:US $ 68.11M 10.19M
Ultragenyx Pharmaceutical RARE:US $ 972.17M 82.41M